Andreas U. Gasser

Andreas U. Gasser

Auto-generated profile, based on publicly available information

Andreas U. Gasser

Department of Cardiology, University Hospital Basel, Basel, Switzerland

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 October 2025 in EP Europace
Verified
Journal Article
Open access
VMVincent Meier
Vincent Meier
SAStefanie Aeschbacher
Stefanie Aeschbacher
MCMichael Coslovsky
Michael Coslovsky
AGAndreas Gasser
Andreas Gasser
RPRebecca E Paladini
Rebecca E Paladini
PKPhilipp Krisai
Philipp Krisai
Aims: Patients with atrial fibrillation (AF) are at a high risk of adverse cardiovascular outcomes. Little is known about the specific population of AF patients with implanted pacemaker (PM) and their prognosis. Therefore, we aimed to compare the risks of adverse outcomes in AF patients with and without PM. Methods and results: Data from two Swiss prospective, multicentre cohort studies (Swiss-AF, Beat-AF) (n = 3675) with yearly follow-ups (FUs) up to 8 years were analysed. The first main outcome was major adverse cardiovascular events (MACE), a composite of stroke or transient ischaemic attack, myocardial infarction, cardiovascular death, and systemic embolism. The second main outcome was hospitalization for heart failure (HF). Secondary outcomes were the individual components of MACE. We performed time-updated Cox regression analyses to investigate the association of PM and outcomes. Median age was 71.4 years, 28.8% female, 445 (12.1%) patients had a PM at baseline, and 238 additional patients (7.4%, 1.05%/year) received a PM over a median FU of 7 years. Patients with a PM had higher incidence rates for MACE and HF (5.97 and 5.08 per 100 patient-years, respectively), compared to patients without a PM (3.37 and 2.61 per 100 patient-years, respectively). After multivariable adjustment, we found no independent association of PM and MACE (aHR [95% CI] 1.12 [0.95–1.33; P = 0.183]) or HF (aHR [95% CI] 1.14 [0.94–1.37; P = 0.180]). We found consistent results for the individual components of MACE. Conclusion: Patients with AF and a PM experienced an increased rate of adverse cardiovascular outcomes. However, the PM itself was not independently associated with these outcomes.

20 March 2026 in Heart Rhythm O2
Verified
Journal Article
Open access
AGAndreas U. Gasser
Andreas U. Gasser
SAStefanie Aeschbacher
Stefanie Aeschbacher
MCMichael Coslovsky
Michael Coslovsky
VMVincent Meier
Vincent Meier
TRTanja Ruoff
Tanja Ruoff
CZChristine S. Zuern
Christine S. Zuern
Recent studies indicate that atrial fibrillation (AF) burden has prognostic implications. We aimed to assess the ability of clinical and cardiac imaging variables to stratify between high and low AF burden. Data from the prospective, multicenter Swiss-AF Burden study were analyzed. Patients underwent a 7-day Holter electrocardiogram and native cardiac magnetic resonance imaging. AF burden, defined as the percentage of time in AF during the 7-day Holter electrocardiogram, was dichotomized into low (<10%) or high (≥10%). Logistic regression models were built, and discriminative performance was evaluated by comparing the area under the curve (AUC). A total of 170 patients were enrolled (median age 72 years; 18% female); 26% (n = 44) had high AF burden. Variables selected for the clinical model were age (odds ratio 1.09; 95% confidence interval 0.40–2.74), male sex (1.05; 1.00–1.11), and body mass index (1.14; 1.06–1.24). The imaging model included left atrial maximal volume index (1.04; 1.01–1.06), left ventricular end-diastolic volume index (0.93; 0.90–0.96), right atrial fractional area change (0.94; 0.89–0.98), and left ventricular ejection fraction (0.87; 0.81–0.94). The AUCs for the clinical and imaging models were 0.67 (0.58–0.77) and 0.91 (0.84–0.98), respectively. Combining both models yielded an AUC of 0.92 (0.86–0.99), with no substantial improvement over the imaging model alone. Cardiac imaging variables clearly outperformed clinical variables in their ability to stratify between high and low AF burden, suggesting their potential as a tool for estimating AF burden.